These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 12093158)

  • 1. Valproate regulates GSK-3-mediated axonal remodeling and synapsin I clustering in developing neurons.
    Hall AC; Brennan A; Goold RG; Cleverley K; Lucas FR; Gordon-Weeks PR; Salinas PC
    Mol Cell Neurosci; 2002 Jun; 20(2):257-70. PubMed ID: 12093158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of GSK-3beta leading to the loss of phosphorylated MAP-1B is an early event in axonal remodelling induced by WNT-7a or lithium.
    Lucas FR; Goold RG; Gordon-Weeks PR; Salinas PC
    J Cell Sci; 1998 May; 111 ( Pt 10)():1351-61. PubMed ID: 9570753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mood-stabilizing agent valproate inhibits the activity of glycogen synthase kinase-3.
    Chen G; Huang LD; Jiang YM; Manji HK
    J Neurochem; 1999 Mar; 72(3):1327-30. PubMed ID: 10037507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic neuroprotective effects of lithium and valproic acid or other histone deacetylase inhibitors in neurons: roles of glycogen synthase kinase-3 inhibition.
    Leng Y; Liang MH; Ren M; Marinova Z; Leeds P; Chuang DM
    J Neurosci; 2008 Mar; 28(10):2576-88. PubMed ID: 18322101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons.
    Yasuda S; Liang MH; Marinova Z; Yahyavi A; Chuang DM
    Mol Psychiatry; 2009 Jan; 14(1):51-9. PubMed ID: 17925795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lithium and valproate act on the GSK-3β signaling pathway to reverse manic-like behavior in an animal model of mania induced by ouabain.
    Valvassori SS; Dal-Pont GC; Resende WR; Jornada LK; Peterle BR; Machado AG; Farias HR; de Souza CT; Carvalho AF; Quevedo J
    Neuropharmacology; 2017 May; 117():447-459. PubMed ID: 27789311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valproate recovers the inhibitory effect of dexamethasone on the proliferation of the adult dentate gyrus-derived neural precursor cells via GSK-3β and β-catenin pathway.
    Boku S; Nakagawa S; Masuda T; Nishikawa H; Kato A; Takamura N; Omiya Y; Kitaichi Y; Inoue T; Kusumi I
    Eur J Pharmacol; 2014 Jan; 723():425-30. PubMed ID: 24211784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lithium blocks stress-induced changes in depressive-like behavior and hippocampal cell fate: the role of glycogen-synthase-kinase-3beta.
    Silva R; Mesquita AR; Bessa J; Sousa JC; Sotiropoulos I; Leão P; Almeida OF; Sousa N
    Neuroscience; 2008 Mar; 152(3):656-69. PubMed ID: 18291594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Axonal remodeling and synaptic differentiation in the cerebellum is regulated by WNT-7a signaling.
    Hall AC; Lucas FR; Salinas PC
    Cell; 2000 Mar; 100(5):525-35. PubMed ID: 10721990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FGF-21, a novel metabolic regulator, has a robust neuroprotective role and is markedly elevated in neurons by mood stabilizers.
    Leng Y; Wang Z; Tsai LK; Leeds P; Fessler EB; Wang J; Chuang DM
    Mol Psychiatry; 2015 Feb; 20(2):215-23. PubMed ID: 24468826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mood stabilizer valproate activates human FGF1 gene promoter through inhibiting HDAC and GSK-3 activities.
    Kao CY; Hsu YC; Liu JW; Lee DC; Chung YF; Chiu IM
    J Neurochem; 2013 Jul; 126(1):4-18. PubMed ID: 23647222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen.
    Phiel CJ; Zhang F; Huang EY; Guenther MG; Lazar MA; Klein PS
    J Biol Chem; 2001 Sep; 276(39):36734-41. PubMed ID: 11473107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WNT-7a induces axonal remodeling and increases synapsin I levels in cerebellar neurons.
    Lucas FR; Salinas PC
    Dev Biol; 1997 Dec; 192(1):31-44. PubMed ID: 9405095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycogen Synthase Kinase-3β as a Putative Therapeutic Target for Bipolar Disorder.
    Dandekar MP; Valvassori SS; Dal-Pont GC; Quevedo J
    Curr Drug Metab; 2018; 19(8):663-673. PubMed ID: 29283064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opposite effects of lithium and valproic acid on trophic factor deprivation-induced glycogen synthase kinase-3 activation, c-Jun expression and neuronal cell death.
    Jin N; Kovács AD; Sui Z; Dewhurst S; Maggirwar SB
    Neuropharmacology; 2005 Mar; 48(4):576-83. PubMed ID: 15755485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of glycogen synthase kinase 3beta in sensory neurons in culture alters filopodia dynamics and microtubule distribution in growth cones.
    Owen R; Gordon-Weeks PR
    Mol Cell Neurosci; 2003 Aug; 23(4):626-37. PubMed ID: 12932442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lithium inhibits neurite growth and tau protein kinase I/glycogen synthase kinase-3beta-dependent phosphorylation of juvenile tau in cultured hippocampal neurons.
    Takahashi M; Yasutake K; Tomizawa K
    J Neurochem; 1999 Nov; 73(5):2073-83. PubMed ID: 10537067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wnt factors in axonal remodelling and synaptogenesis.
    Salinas PC
    Biochem Soc Symp; 1999; 65():101-9. PubMed ID: 10320935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lithium and synaptic plasticity.
    Salinas PC; Hall AC
    Bipolar Disord; 1999 Dec; 1(2):87-90. PubMed ID: 11252664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphocyte Phospho-Ser-9-GSK-3β/Total GSK-3β Protein Levels Ratio Is Not Affected by Chronic Lithium or Valproate Treatment in Euthymic Patients With Bipolar Disorder.
    Azab AN; Vainer E; Agam G; Bersudsky Y
    J Clin Psychopharmacol; 2017 Apr; 37(2):226-230. PubMed ID: 28106616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.